» Articles » PMID: 39716240

AttenhERG: a Reliable and Interpretable Graph Neural Network Framework for Predicting HERG Channel Blockers

Overview
Journal J Cheminform
Publisher Biomed Central
Specialty Chemistry
Date 2024 Dec 24
PMID 39716240
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiotoxicity, particularly drug-induced arrhythmias, poses a significant challenge in drug development, highlighting the importance of early-stage prediction of human ether-a-go-go-related gene (hERG) toxicity. hERG encodes the pore-forming subunit of the cardiac potassium channel. Traditional methods are both costly and time-intensive, necessitating the development of computational approaches. In this study, we introduce AttenhERG, a novel graph neural network framework designed to predict hERG channel blockers reliably and interpretably. AttenhERG demonstrates improved performance compared to existing methods with an AUROC of 0.835, showcasing its efficacy in accurately predicting hERG activity across diverse datasets. Additionally, uncertainty evaluation analysis reveals the model's reliability, enhancing its utility in drug discovery and safety assessment. Case studies illustrate the practical application of AttenhERG in optimizing compounds for hERG toxicity, highlighting its potential in rational drug design.Scientific contributionAttenhERG is a breakthrough framework that significantly improves the interpretability and accuracy of predicting hERG channel blockers. By integrating uncertainty estimation, AttenhERG demonstrates superior reliability compared to benchmark models. Two case studies, involving APH1A and NMT1 inhibitors, further emphasize AttenhERG's practical application in compound optimization.

References
1.
Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2020; 49(D1):D1388-D1395. PMC: 7778930. DOI: 10.1093/nar/gkaa971. View

2.
Lee H, Yu M, Kazmi S, Oh S, Rhee K, Bae M . Computational determination of hERG-related cardiotoxicity of drug candidates. BMC Bioinformatics. 2019; 20(Suppl 10):250. PMC: 6538553. DOI: 10.1186/s12859-019-2814-5. View

3.
Sun F, Sun J, Zhao Q . A deep learning method for predicting metabolite-disease associations via graph neural network. Brief Bioinform. 2022; 23(4). DOI: 10.1093/bib/bbac266. View

4.
Wang J, Zhang L, Sun J, Yang X, Wu W, Chen W . Predicting drug-induced liver injury using graph attention mechanism and molecular fingerprints. Methods. 2023; 221:18-26. DOI: 10.1016/j.ymeth.2023.11.014. View

5.
Darpo B, Nebout T, Sager P . Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline. J Clin Pharmacol. 2006; 46(5):498-507. DOI: 10.1177/0091270006286436. View